Skip to main content
Log in

Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver

  • Metabolic Activation/Inactivation
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The effects of diabetes on cytochrome P450 (CYP)-dependent drug metabolizing enzymes are yet to be clarified. The most widely used animals in these studies have been rats, and information on the effects of diabetes on rabbit liver drug metabolizing enzymes have been unavailable until now. In this study, for the first time, a significant induction of liver CYP2E1 is demonstrated via immunoblot analysis in alloxan-induced rabbits. The CYP2E1 content of diabetic microsomes was highly correlated with the activities of liver aniline 4-hydroxylase (r=0.82, p<0.05), and p-nitrophenol hydroxylase (r=0.86, p<0.01), and diabetes increased the activities of the enzymes associated with CYP2E1. The activities of aniline 4-hydroxylase and p-nitrophenol hydroxylase were significantly increased by 1.7 and 1.8-fold, respectively compared to those of control rabbits. In marked contrast, diabetes had no effect on the protein levels of CYP2B4 as determined by immunoblotting and on benzphetamine N-demethylase activity, which is known to be specifically metabolized by CYP2B4 in rabbit liver. The present study demonstrates that diabetes increases the activities of CYP2E1 and associated enzymes but does not change the activity levels of CYP2B4 and associated enzymes in diabetic rabbits. These findings are in contrast to those of mice, hamsters and rats, and that suggest the presence of species-dependent responses of CYP-dependent drug metabolizing enzymes to diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–B
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Arinç E (1993) Extrahepatic microsomal forms: Lung microsomal cytochrome P450 isozymes. In: Schenkman JB, Greim H (eds) Handbook of experimental pharmacology, cytochrome P450, vol 105. Springer, Berlin Heidelberg New York, pp 373–386

  • Arinç E, Iscan M (1983) Comparative studies of sheep liver and lung microsomal aniline 4-hydroxylase. Comp Biochem Physiol 74C:151–158

    Article  Google Scholar 

  • Arinç E, Philpot RM (1976) Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem 25:3213–3220

    Google Scholar 

  • Arinç E, Adali O, Iscan MY, Güray T (1991) Stimulatory effects of benzene on rabbit liver and kidney microsomal cytochrome P-450 dependent drug metabolizing enzymes. Arch Toxicol 65:186–190

    PubMed  Google Scholar 

  • Arinç E, Hanukoglu I, Sen A, Adali O (1995) Tissue-and-species dependent expression of sheep lung microsomal cytochrome P4502B (LgM2). Biochem Mol Biol Int 37:1121–1126

    PubMed  Google Scholar 

  • Arinç E, Adali O, Gençler-Özkan AM (2000a) Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 74:329–334

    Article  Google Scholar 

  • Arinç E, Adali O, Gençler-Özkan AM (2000b) Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine treatments of rabbits. Arch Toxicol 74:527–532

    Article  PubMed  Google Scholar 

  • Barnett CR, Flatt PR, Ionnides C (1990) Induction of hepatic microsomal P450I and IIB proteins by hyperketonaemia. Biochem Pharmacol 40:393–397

    Article  CAS  PubMed  Google Scholar 

  • Billing RE (1985) Mechanism of catechol formation from aromatic compounds in isolated rat hepatocytes. Drug Metab Dispos 13:287–290

    PubMed  Google Scholar 

  • Bolt HM, Roos PH, Thier R (2003) The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174–185

    CAS  PubMed  Google Scholar 

  • Bonfils C, Combalbert J, Pineau T, Angevin J, Larroque C, Derancourt J, Capony JP, Maurel P (1990) Ontogenesis of rabbit liver cytochrome P450. Evidence for a cytochrome P450-IIE (3a)-related form prevailing during the post-natal period. Eur J Biochem 188:187–194

    Article  CAS  PubMed  Google Scholar 

  • Bonfils C, Combalbert J, Pineau T, Larroque C, Lange R, Maurel P (1991) Ontogenesis of liver cytochrome P450. In: Arinc E, Schenkman JB, Hodgson E (eds) Molecular aspects of monooxgenases and bioactivation of toxic compounds NATO ASI series, series A: life sciences, vol 202. Plenum, New York, pp 255–266

  • Chen TL, Chen SH, Tai TY, Chao CC, Park SS, Guengerich FP, Veng TH (1996) Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters. Arch Toxicol 70:202–208

    Article  CAS  PubMed  Google Scholar 

  • Cochin J, Axelrod J (1959) Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine, and normorphine. Pharmacol Exp Ther 125:105–110

    CAS  Google Scholar 

  • Ding X, Pernecky JS, Coon MJ (1991) Purification and characterization of cytochrome P4502E2 from hepatic microsomes of neonatal rabbits. Arch Biochem Biophys 291:270–276

    Article  CAS  PubMed  Google Scholar 

  • Dong ZG, Hong JY, Ma QA, Li DC, Bullock J, Gonzalez FJ, Park SS, Gelboin HV, Yang CS (1988) Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch Biochem Biophys 263:29–35

    Article  CAS  PubMed  Google Scholar 

  • Ekstrom G, Ingelman-Sundberg M (1989) Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38:1313–1319

    Article  CAS  PubMed  Google Scholar 

  • Ey PL, Ashman LK (1986) The use of alkaline phosphatase-conjugated anti-immunoglobulin with immunoblots for determining the specificity of monoclonal antibodies to protein mixtures. In: Langone JJ, Vunakis HV (eds) Methods in enzymology, vol 121. Academic, New York, pp 497–509

  • Favreau LV, Schenkman JB (1988) Composition changes in hepatic microsomal cytochrome P450 during onset of streptozotocin-induced diabetes and during insulin treatment. Diabetes 37:577–584

    CAS  PubMed  Google Scholar 

  • Fu X, Chen TS, Ray MB, Nagasawa HT, Williams WM (2004) p-Aminophenol-induced hepatotoxicity in hamsters: role of glutathione. J Biochem Mol Toxicol 18:154–161

    Article  CAS  PubMed  Google Scholar 

  • Funae Y, Imaoka S (1993) Cytochrome P450 in rodents. In: Schenkman JB, Greim H (eds) Handbook of experimental pharmacology, cytochrome P450, vol 105. Springer, Berlin Heidelberg New York, pp 221–238

  • Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168–179

    Article  CAS  PubMed  Google Scholar 

  • Haugen DA, Coon MJ (1976) Properties of electrophoretically homogeneous phenobarbital-inducible and β-naphtoflavone-inducible forms of liver microsomal cytochrome P450. J Biol Chem 251:7929–7939

    CAS  PubMed  Google Scholar 

  • Johansson I, Ingelman-Sundberg M (1988) Benzene metabolism by ethanol-inducible, acetone-inducible, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 48:5387–5390

    CAS  PubMed  Google Scholar 

  • Kharasch ED, Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79:795–807

    CAS  PubMed  Google Scholar 

  • Kim SG, Philpot RM, Novak RF (1991) Pyridine effects on P450IIE1, IIB and IVB expression in rabbit liver: Characterization of high- and low-affinity pyridine N-oxygenases. J Pharmacol Exp Ther 259:470–477

    CAS  PubMed  Google Scholar 

  • Knodell RG, Handwerger BS, Morley JE, Levine AS, Brown DM (1984) Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetus mellitus. J Pharmacol Exp Ther 230:256–262

    CAS  PubMed  Google Scholar 

  • Koop DR (1986) Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450 isozyme 3a. Mol Pharmacol 29:399–404

    CAS  PubMed  Google Scholar 

  • Koop DR, Morgan ET, Tarr GE, Coon MJ (1982) Purification and characterization of a unique isozyme of cytochrome P450 from liver microsomes of ethanol-treated rabbits. J Biol Chem 257:8472–8480

    CAS  PubMed  Google Scholar 

  • Koop DR, Crump BL, Nordblom GD, Coon MJ (1985) Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole, and isoniazid. Proc Natl Acad Sci USA 82:4065–4069

    CAS  PubMed  Google Scholar 

  • Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685

    CAS  PubMed  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin Phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  • Lu AYH, Levin W (1974) The resolution and reconstitution of the liver microsomal hydroxylation system. Biochem Biophys Acta 344:205–240

    CAS  PubMed  Google Scholar 

  • Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416–421

    CAS  PubMed  Google Scholar 

  • Nebert DW, Gonzales FJ (1987) P-450 genes: structure, evolution, and regulation. Ann Rew Biochem 56:945–993

    Article  CAS  Google Scholar 

  • Omura T, Sato R (1964) The carbon monoxide of liver binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 239:2379–2385

    CAS  PubMed  Google Scholar 

  • Öztürk Y, Altan, VM, Yildizoglu-Ari N (1996) Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 48:69–112

    PubMed  Google Scholar 

  • Past MR, Cook DE (1982) Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450. Biochem Pharmacol 31:3329–3334

    Article  CAS  PubMed  Google Scholar 

  • Peng R, Tennant P, Lorr NA, Yang CS (1983) Alterations of microsomal monooxygenase system and carcinogen metabolism by streptozotocin-induced diabetes in rats. Carcinogenesis 4:703–708

    CAS  PubMed  Google Scholar 

  • Persson JO, Terelius Y, Ingelman-Sundberg M (1990) Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 20:887–900

    CAS  PubMed  Google Scholar 

  • Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566–573

    Article  CAS  PubMed  Google Scholar 

  • Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB (1990) Induction of cytochrome P450IIE1 in the obese over-fed rat. Mol Pharmacol 39:275–280

    Google Scholar 

  • Reinke LA, Moyer MJ (1985) p-Nitrophenol hydroxylation. A microsomal oxidation, which is highly inducible by ethanol. Drug Metab Dispos 13:548–552

    CAS  PubMed  Google Scholar 

  • Rich JR, Boobis AR (1997) Expresión and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech 39:424–435

    Article  CAS  PubMed  Google Scholar 

  • Sakuma T, Honma R, Maguchi S, Tamaki H, Nemoto N (2001) Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica 31:223–237

    Article  CAS  PubMed  Google Scholar 

  • Serabjit-Sing CJ, Wolf CR, Philpot RM (1979) The rabbit pulmonary monooxygenase system. Immunochemical and biochemical characterization of enzyme components. J Biol Chem 254:9901–9907

    PubMed  Google Scholar 

  • Shimojo N, Ishizaki T, Imaoka S, Funae Y, Fuji S, Okuda K (1993) Changes in amount of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochem Pharmacol 46:621–627

    Article  CAS  PubMed  Google Scholar 

  • Song H, Chen TS (1995) Mouse and rat differences in p-aminophenol toxicity. Toxic Subst Mech 14:307–325

    CAS  Google Scholar 

  • Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; procedure and some applications. Proc Nat Acad Sci USA 76:4350–4354

    CAS  PubMed  Google Scholar 

  • Villeneuve JP, Pichette V (2004) Cytochrome p450 and liver diseases. Curr Drug Metab 5:273–282

    Article  CAS  PubMed  Google Scholar 

  • Wang T, Shankar M, Ronis MJJ, Mehendale HM (2000) Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J Pharmacol Exp Ther 294:473–479

    CAS  Google Scholar 

  • Wang Z, Hall SD, Maya JF, Li L, Asghar A, Gorski JC (2003) Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol 55:77–85

    Article  CAS  PubMed  Google Scholar 

  • Watanabe M (1999) Genetic polymorphisms of cytochrome P450 1A1 and 2E1 and of glutathione S-transferase M1 and cancer susceptibility in the human. In: Arinc E, Schenkman JB, Hodgson E (eds) Molecular and applied aspects of oxidative drug metabolizing enzymes. NATO ASI series, series A: life sciences, vol 303. Kluwer Academic/Plenum, New York, pp 127–143

  • Wolf KK, Wood SG, Bement JL, Sinclair PR, Wrighton SA, Jeffery E, Gonzalez FJ, Sinclair JF (2004) Role of mouse CYP2E1 in the O-hydroxylation of p-nitrophenol: comparison of activities in hepatic microsomes from Cyp2e1 (−/−) and wild-type mice. Drug Metab Dispos 32:681–684

    Article  CAS  PubMed  Google Scholar 

  • Yang CS, Hong JY (1995) Molecular aspects of cytochrome P4502E1 and its roles in chemical toxicology. In: Arinc E, Schenkman JB, Hodgson E (eds) Molecular aspects of oxidative drug metabolizing enzymes: their significance in environmental toxicology, chemical carcinogenesis and health NATO ASI series, series H: cell biology, vol 90. Springer, Berlin Heidelberg New York, pp 181–192

    Google Scholar 

Download references

Acknowledgments

This study was supported in part by Turkish Academy of Sciences (TüBA) and Middle East Technical University Research Project Fund (Project No.: BAP-2002-01-08-01). The authors thank to Middle East Technical University Health Center for the analysis of blood constituents.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emel Arınç.

Additional information

An account of this work was presented at the 19th European Workshop on Drug Metabolism, DMW-2004, in Antalya, Turkey, on 3–8 October 2004

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arınç, E., Arslan, Ş. & Adalı, O. Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver. Arch Toxicol 79, 427–433 (2005). https://doi.org/10.1007/s00204-005-0654-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-005-0654-8

Keywords

Navigation